{
    "nct_id": "NCT04724499",
    "official_title": "Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy (The CLARITY Trial)",
    "inclusion_criteria": "* Written informed consent prior to any study-related procedures\n* Women newly diagnosed (Stage I-III) breast cancer.\n* Over the age of 18 years; children under the age of 18 will be excluded due to rarity of disease\n* The effects of exercise on the developing fetus are unknown. For this reason, women of child-bearing potential must agree to undergo a pregnancy test and to use adequate contraception (hormonal or barrier method of birth control or abstinence) prior to study entry and for six months following duration of study participation. Should a woman become pregnant or suspect that she is pregnant while participating on the trial, she should inform her treating physician immediately.\n* Will receive (neo)adjuvant chemotherapy\n* Speak English\n* Able to provide physician clearance to participate in the exercise program\n* Able to initiate a supervised exercise program (free from any cardiovascular, respiratory or musculoskeletal disease or joint problems that preclude moderate physical activity)\n* Have not experienced a weight reduction â‰¥10% within the past 6 months\n* Currently participate in less than 60 minutes of structured exercise/week\n* Does not smoke (no smoking during previous 12 months)\n* Willing to travel to DFCI for assessments (54 visits total for those who elect the exercise group with on campus training session, 6 visits for those that elect the exercise at home option, 6 visits for those assigned to the control group)\n* Ability to understand and the willingness to sign a written informed consent document.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients should not have any uncontrolled illness including ongoing or active infection, uncontrolled diabetes, hypertension or thyroid disease\n* Patients with other active malignancies are ineligible for this study.\n* Patients with metastatic disease\n* Medical history of coronary heart or artery disease, chronic or acute congestive heart failure or history of systolic or diastolic insufficiencies\n* Participates in more than 60 minutes of structured exercise/week\n* Orthopedic or other restrictions or contraindications to high-intensity (cycling) exercise\n* Have a pacemaker or any implantable device that are not MRI safe; the BWH/DFCI Standard MRI screening form\n* Is unable to travel to DFCI\n* Patients who are pregnant\n* Patients with claustrophobia\n* Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study.",
    "miscellaneous_criteria": ""
}